49 Past, present, and future of red blood cells 35. Ballard SSJ, Murphy MF. Changing indications for red cell transfusion. Transfus Med 2007;17:315-6 author reply 7. 36. Pham JC, Catlett CL, Berenholtz SM, et al. Change in use of allogeneic red blood cell transfusions among surgical patients. J Am Coll Surg 2008;207:352-9. 37. Yoshihara H, Yoneoka D. National trends in the utilization of blood transfusions in total hip and knee arthroplasty. J Arthroplasty 2014;29:1932-7. 38. McWilliams B, Triulzi DJ, Waters JH, et al. Trends in RBC ordering and use after implementing adaptive alerts in the electronic computerized physician order entry system. Am J Clin Pathol 2014;141:534-41. 39. Goodnough T, Baker SA, Shah N. How I use clinical decision support to improve red blood cell utilization. Transfusion 2016; 56:2406-11. 40. Roubinian NH, Escobar GJ, Liu V, et al. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion 2014;54:2678-86. 41. Yerrabothala S, Desrosiers KP, Szczepiorkowski ZM, et al. Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive trans- fusion policy supported by prospective computerized order auditing. Transfusion 2014;54:2640-5. 42. Greinacher A, Weitmann K, Schonborn L, et al. A population- based longitudinal study on the implication of demographic changes on blood donation and transfusion demand. Blood Adv 2017;1:867-74. 43. Bessos H, Fraser R, Seghatchian J. Scotblood 2010: key presentations of the past, present, and future of transfusion medicine to mark Scottish national blood transfusion service (SNBTS) anniversaries. Transfus Apher Sci 2011;45:213-21. 44. Raphael JL, Oyeku SO, Kowalkowski MA, et al. Trends in blood transfusion among hospitalized children with sickle cell disease. Pediatr Blood Cancer 2013;60:1753-8. 45. Wahl S, Quirolo KC. Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr 2009;21:15-21. 46. Drasar E, Igbineweka N, Vasavda N, et al. Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years. Br J Haematol 2011;152: 766-70. 47. Howard J, Malfroy M, Llewelyn C, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet 2013; 381:930-8. 48. Ford JBPJA, Seeho SK, Roberts CL. Trends and outcomes of postpartum haemorrhage, 2003-2011. BMC Pregnancy Child- birth 2015;15:334. 49. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemor- rhage Collaborative Group. BMC Pregnancy Childbirth 2009;9:55.
RkJQdWJsaXNoZXIy MTk4NDMw